InterCure

INCR · TEL

$4.43−$0.03 (−0.67%)TodayMarket closed · Oct 20, 7:30 PM ET

Prev close $4.46

About INCR

InterCure Ltd. engages in the provision of business of medical cannabis and biomedicine. Thorugh its wholly owned subsidiary Canndoc the Company operates as licensed cannabis producer and one of the first to offer Good Manufacturing Practices (GMP) certified and pharmaceutical-grade medical cannabis products.

Employees: 320
Headquarters: Herzliya
Listed: Jul 26, 2007
Sector: Health Care
Industry: Pharmaceuticals
Website: intercure.co

Leadership

InterCure executives
Name	Title	Since	Age
Ehud Barak	—	2018	81
Alexander Rabinovitch	—	2018	51
Amos Cohen	—	—	42
Rami Levy	—	—	—
Ori Mimon	—	—	—
Adv. Asaf Ohyaon	—	—	—
Alon Granot	—	—	61
Lennie Grinbaum Michelson	—	—	46
Gideon Hirschfeld	—	—	56
David Salton	—	—	72

Revenue by product and region

Fiscal year ended Dec 31, 2024: $238.84M total revenue

By product

Cannabis segment [member]$238.84M100.0%
Reportable segments [member]$238.84M100.0%

Similar companies

Companies in the same industry as InterCure

Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.